Table 2.

Details of GO terms and KEGG pathway enrichment in GSE211378.

Ontology	ID	Description	GeneRatio	BgRatio	p value	p. Adjust
BP	GO:0019221	Cytokine-mediated signaling pathway	107/298	486/18800	1.85e-94	7.49e-91
BP	GO:0001819	Positive regulation of cytokine production	73/298	475/18800	3.89e-51	7.86e-48
BP	GO:0070661	Leukocyte proliferation	59/298	330/18800	5.31e-45	7.16e-42
BP	GO:0070663	Regulation of leukocyte proliferation	50/298	254/18800	3.08e-40	3.12e-37
BP	GO:0070665	Positive regulation of leukocyte proliferation	42/298	158/18800	1.04e-39	8.4e-37
CC	GO:0009897	External side of plasma membrane	47/299	455/19594	1.46e-25	4.82e-23
CC	GO:0030667	Secretory granule membrane	27/299	312/19594	3.65e-13	6.01e-11
CC	GO:0098857	Membrane microdomain	27/299	327/19594	1.12e-12	1.23e-10
CC	GO:0045121	Membrane raft	26/299	326/19594	6.56e-12	5.4e-10
CC	GO:0098802	Plasma membrane signaling receptor complex	25/299	313/19594	1.64e-11	1.08e-09
MF	GO:0005126	Cytokine receptor binding	60/298	272/18410	5.35e-51	2.8e-48
MF	GO:0005125	Cytokine activity	48/298	235/18410	5.11e-39	1.34e-36
MF	GO:0004896	Cytokine receptor activity	33/298	97/18410	4.62e-35	6.82e-33
MF	GO:0140375	Immune receptor activity	38/298	148/18410	5.22e-35	6.82e-33
MF	GO:0048018	Receptor ligand activity	50/298	489/18410	7.6e-26	7.95e-24
KEGG	hsa04060	Cytokine-cytokine receptor interaction	80/260	295/8164	9.7e-55	2.45e-52
KEGG	hsa05417	Lipid and atherosclerosis	48/260	215/8164	4.95e-28	6.26e-26
KEGG	hsa04630	JAK–STAT signaling pathway	42/260	162/8164	2.38e-27	2.01e-25
KEGG	hsa04061	Viral protein interaction with cytokine and cytokine receptor	34/260	100/8164	1.35e-26	8.55e-25
KEGG	hsa04659	Th17 cell differentiation	34/260	108/8164	2.53e-25	1.28e-23